CompletedPhase 2NCT03805581

Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome

Studying Sickle cell disease

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
New York Medical College
Principal Investigator
Mitchell S Cairo, MD, MD, MPH
New York Medical College
Intervention
Defibrotide(drug)
Enrollment
20 enrolled
Eligibility
2-40 years · All sexes
Timeline
2018 – 2023

Study locations (1)

Collaborators

Johns Hopkins University

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03805581 on ClinicalTrials.gov

Other trials for Sickle cell disease

Additional recruiting or active studies for the same condition.

See all trials for Sickle cell disease →

← Back to all trials